Non-Invasive Prenatal Testing Market Competitive Landscape, Research Methodology, Business Opportunities, Statistics and Industry Analysis Report by 2027

The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out.

Transcript

1. Non-Invasive Prenatal Testing Market 2020 - 2028 www.emergenresearch.com The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research.
2. Custom Research Custom Market Intelligen ce Competito r Analysis Market Analysi s Distributi on Channel Analysis Risk Analysis Financia l Analysis Brand Analysis Product Analysis Demand Analysis Our Model w w w . e m e r g e n r e s e a r c h . c o m
3. End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility Customer Identification Survey Competitive Landscape / M&A Feasibility w w w . e m e r g e n r e s e a r c h . c o m Business Plan Parameters w w w . e m e r g e n r e s e a r c h . c o m
4. Industries We Cater to 5 Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings Materials and Chemicals Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce Information and Tech Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Food & Beverages Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Pharma & Healthcare Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Power & Energy Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Automotive Services w w w . e m e r g e n r e s e a r c h . c o m
5. The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes. Despite NIPT being accessible in growing amounts of regions, there is a major commercial push expected to assist consumer expansion in the projected years. NIPT was confirmed through similarities with standard prenatal aneuploidy screening and found to be a beneficial screening procedure with keen sensitivity and specificity. Increasing popularity among pregnant women as an alternative to amniocentesis and awareness of prenatal genetic problems drives non-invasive prenatal testing. Key players in the market Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others. Get a sample of the report - https://www.emergenresearch.com/request-sample/16 Market Summary www.emergenresearch.com
6. Some Key Highlights From the Report • Based on the method, ultrasound detection generated a revenue of USD 0.86 billion in 2019 and believed to rise with a CAGR of 14.0% in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb. • The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies. • The trisomy application is the major contributor to the Non-Invasive Prenatal Testing Market. The trisomy application of the North America region is the major shareholder of the market and held around 45.1% of the market in the year 2019, owing to the high incidence of genetic disorders correlated with trisomy’s, such as Patau syndrome, Down syndrome, and Edward syndrome. Market Summary
7. For the purpose of this report, Emergen Research has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, and region: Method Outlook (Revenue, USD Billion; 2017-2027) Ultrasound Detection Biochemical Screening Tests End-Use Outlook (Revenue, USD Billion; 2017-2027) Diagnostic Laboratories Hospitals Regional Outlook (Revenue, USD Billion; 2017-2027) North America Europe Asia Pacific MEA Latin America To read more about the report, visit - https://www.emergenresearch.com/industry-report/non-invasive-prenatal- testing-market Market Summary
8. www.emergenresearch.com MARKET SEGMENTATION Parameter Details Market Size Estimation Period 2020-2028 Base Year Considered 2020 Historical Data 2017-2019 Forecast Period 2021-2028 Quantitative Units Revenue in USD million & CAGR from 2020 to 2028 Segments Covered Types, Application, End-Users, Regions & more. Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa Customization Scope 10 hours of free customization & expert consultation Pricing and Purchase Options Explore Different Purchase Options & Request for Discount to Avail New Year Discount
9. w w w . e m e r g e n r e s e a r c h . c o m Regional Share Dynamics
10. Latest published reports from the Healthcare Sector by Emergen Research Read similar reports by Emergen Research: Nanopharmaceutical Drugs Market @: https://www.emergenresearch.com/industry-report/nanopharmaceutical- drugs-market Clinical Perinatal Software Market @: https://www.emergenresearch.com/industry-report/clinical-perinatal-software- market Human Microbiome Modulators Market @: https://www.emergenresearch.com/industry-report/human-microbiome- modulators-market In Silico Drug Discovery Market @: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery- market Blockchain in Genomics Market @: https://www.emergenresearch.com/industry-report/blockchain-in-genomics- market LATEST PUBLICATIONS w w w. e m e rg e n re s e a rc h . co m
11. At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. w w w . e m e r g e n r e s e a r c h . c o m About Us
12. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. sales@emergenresearch.com www.emergenresearch.com 14671 110 Avenue, Surrey, British Columbia, V3R2A9 +1 (604) 757-9756 w w w . e m e r g e n r e s e a r c h . c o m